JP2023071886A5 - - Google Patents

Download PDF

Info

Publication number
JP2023071886A5
JP2023071886A5 JP2023033133A JP2023033133A JP2023071886A5 JP 2023071886 A5 JP2023071886 A5 JP 2023071886A5 JP 2023033133 A JP2023033133 A JP 2023033133A JP 2023033133 A JP2023033133 A JP 2023033133A JP 2023071886 A5 JP2023071886 A5 JP 2023071886A5
Authority
JP
Japan
Prior art keywords
surfactant
pharmaceutical composition
pulmonary
particles
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023033133A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023071886A (ja
JP7629159B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2017/039094 external-priority patent/WO2017223502A1/en
Application filed filed Critical
Publication of JP2023071886A publication Critical patent/JP2023071886A/ja
Publication of JP2023071886A5 publication Critical patent/JP2023071886A5/ja
Application granted granted Critical
Publication of JP7629159B2 publication Critical patent/JP7629159B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023033133A 2016-06-24 2023-03-03 吸入用サーファクタント製剤 Active JP7629159B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201662354382P 2016-06-24 2016-06-24
US62/354,382 2016-06-24
US201662420932P 2016-11-11 2016-11-11
US62/420,932 2016-11-11
PCT/US2017/039094 WO2017223502A1 (en) 2016-06-24 2017-06-23 Surfactant formulations for inhalation
JP2018567655A JP7240178B2 (ja) 2016-06-24 2017-06-23 吸入用サーファクタント製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018567655A Division JP7240178B2 (ja) 2016-06-24 2017-06-23 吸入用サーファクタント製剤

Publications (3)

Publication Number Publication Date
JP2023071886A JP2023071886A (ja) 2023-05-23
JP2023071886A5 true JP2023071886A5 (enExample) 2024-02-27
JP7629159B2 JP7629159B2 (ja) 2025-02-13

Family

ID=59295343

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018567655A Active JP7240178B2 (ja) 2016-06-24 2017-06-23 吸入用サーファクタント製剤
JP2023033133A Active JP7629159B2 (ja) 2016-06-24 2023-03-03 吸入用サーファクタント製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018567655A Active JP7240178B2 (ja) 2016-06-24 2017-06-23 吸入用サーファクタント製剤

Country Status (9)

Country Link
US (2) US20190388444A1 (enExample)
EP (1) EP3474832B1 (enExample)
JP (2) JP7240178B2 (enExample)
AU (2) AU2017281931B2 (enExample)
CA (1) CA3028724A1 (enExample)
MA (1) MA45451A (enExample)
MX (2) MX2018015969A (enExample)
WO (1) WO2017223502A1 (enExample)
ZA (1) ZA201900337B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3474832B1 (en) * 2016-06-24 2026-03-18 Merz Pharmaceuticals, LLC Surfactant formulations for inhalation
WO2019126283A1 (en) * 2017-12-21 2019-06-27 Civitas Therapeutics, Inc. Surfactant formulations for inhalation
WO2019126289A1 (en) * 2017-12-21 2019-06-27 Civitas Therapeutics, Inc. Surfactant formulations for inhalation
US20240025970A1 (en) * 2020-10-16 2024-01-25 Sherwood Russ Lehrman Lung treatment compositions
WO2023281523A1 (en) * 2021-07-09 2023-01-12 Indian Council Of Medical Research A pharmaceutical composition with a recombinant fragment of human surfactant protein-d for sars-cov-2 infection

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
CZ292186B6 (cs) * 1996-01-24 2003-08-13 Altana Pharma Ag Způsob výroby práškového prostředku s obsahem plicní povrchově aktivní látky, práškový prostředek a jeho použití
US6586008B1 (en) * 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US20030091509A1 (en) * 2000-02-11 2003-05-15 Haefner Dietrich Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
WO2007084136A2 (en) * 2006-01-23 2007-07-26 Ony, Inc. Treatment of acute respiratory distress syndrome
US20070224310A1 (en) * 2006-03-22 2007-09-27 Wm. Wrigley Jr. Company Compressed gum
EP2049554A4 (en) 2006-07-20 2011-06-29 Univ Rochester Medical Ct SYNTHETIC LUNG SURFAKTANT AND ITS USE
WO2008016497A2 (en) * 2006-07-31 2008-02-07 Corn Products International, Inc. Isomaltitol compositions and process for making isomaltitol compositions
US8496002B2 (en) 2007-06-12 2013-07-30 Civitas Therapeutics, Inc. Powder inhaler devices
WO2009026434A1 (en) * 2007-08-21 2009-02-26 Alkermes, Inc. Pulmonary pharmaceutical formulations
EP3474832B1 (en) 2016-06-24 2026-03-18 Merz Pharmaceuticals, LLC Surfactant formulations for inhalation

Similar Documents

Publication Publication Date Title
JP2023071886A5 (enExample)
CA2689066C (en) Reconstituted surfactants having improved properties
EP2438086B1 (en) Improved reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c)
US8221772B2 (en) Pulmonary surfactant formulations and methods for promoting mucus clearance
JPH10511090A (ja) 副甲状腺ホルモン,pth含有吸入用治療製剤
EP2078038A1 (en) Reconstituted surfactants having improved properties
WO2005055994A1 (en) Treatment and preventions of asthma
JPWO2020055824A5 (enExample)
WO2017155857A1 (en) COMPOSITIONS AND METHODS FOR ADMINISTERING PPARγ AGONISTS, SURFACTANT PEPTIDES AND PHOSPHOLIPIDS
KR102395835B1 (ko) 재구성된 폐 계면활성제 조성물을 포함하는 안정한 약제학적 제제
JP2023546297A (ja) 肺治療組成物
JP2003501481A (ja) サーファクタントタンパク質b(sp−b)改変体およびサーファクタントタンパク質c(sp−c)改変体を含有する医薬品製剤
JPWO2021028679A5 (enExample)
WO2014012559A1 (en) Granulocyte-macrophage colony-stimulating factor for the treatment of bronchial asthma
NZ765394B2 (en) Surfactant formulations for inhalation
NZ765394A (en) Surfactant formulations for inhalation
WO2015110536A1 (en) Granulocyte-macrophage colony-stimulating factor for the treatment and prevention of severe forms of bronchial asthma
RS20170169A1 (sr) Poboljšana rekonstituisana kompozicija sufraktanta koja sadrži analoge sufraktanta proteina b (sp-b) i surfaktanta proteina c (sp-c)
JP2003502441A (ja) サーファクタントタンパク質cエステル